CytoVale key facts
- Developer of biophysical markers designed to revolutionize diagnostics using cell mechanics and machine learning.
- CytoVale’s last known valuation is $340.0M.
- It has raised $228.2M across 3 recorded rounds; the latest was Debt ($16.4M) in Dec 2020.
- Notable investors include Alumni Ventures, US National Science Foundation, Google for Startups, National Institutes of Health, Western Technology Investment — 35 tracked in total.
- CytoVale has filed 4 Form Ds with the SEC since 2017, most recently Jan 2022 ($16.4M sold to 23 investors).
- Status: Privately Held (backing).
Who backs CytoVale
35+- ·The complete investor list: 35 names
- ·Watch CytoVale: the Monday email on marks, rounds and moves
CytoVale funding rounds
3 roundsCytoVale valuation
CytoVale's last known valuation is $340 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has CytoVale raised?
CytoVale has raised $228 million in total; 3 of its rounds are on record, from 2017 on. The largest on record was a $7.4 million early-stage round in Oct 2019; the most recent was a $16.4 million debt round in Dec 2020.
CytoVale has filed 4 Form Ds with the SEC since 2017, most recently in Jan 2022 ($16.4 million sold to 23 investors).
CytoVale investors
35 investors are on record for CytoVale, including Alumni Ventures, US National Science Foundation, Google for Startups and National Institutes of Health. By type, the record holds 5 venture capital firms and 1 growth equity firm. The debt round in Dec 2020 drew 23 investors.
About CytoVale
Developer of biophysical markers designed to revolutionize diagnostics using cell mechanics and machine learning. The company's biomarkers are based on the mechanical properties of individual cells by using microfluidics to route and probe cells which can measure multiple biomarkers at one time, enabling physicians to detect early symptoms of sepsis, improve patient outcomes and reduce treatment costs.
- Sector
- Healthcare
- HQ
- South San Francisco, CA, United States
- Founded
- 2013
- Employees
- 124
- Website
- cytovale.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
CytoVale’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.